Various classes of mutations in patients with phosphofructokinase deficiency (Tarui's disease)
Nina Raben(APT Therapeutics (United States)), Paul H. Plötz(National Institutes of Health), Zohar Argov(Hebrew University of Jerusalem), Jeffrey B. Sherman(National Institutes of Health), Elizabeth M. Adams(National Institutes of Health), Hiromu Nakajima(Osaka Medical Center for Cancer and Cardiovascular Diseases)
Cited by 14
Related Papers
Therapy of Lupus Nephritis
|New England Journal of Medicine|1986|1.2k
A New Approach to the Classification of Idiopathic Inflammatory Myopathy
|Medicine|1991|974
Defective Reticuloendothelial System Fc-Receptor Function in Systemic Lupus Erythematosus
|New England Journal of Medicine|1979|531
Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy
|The Journal of Experimental Medicine|2005|395